Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Study to Compare Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media (AR01007)

ClinicalTrials.gov ID: NCT02074007

Public ClinicalTrials.gov record NCT02074007. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 2:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Placebo-controlled, Double-blind, Randomized Study to Compare the Efficacy and Safety of AR01 Otic Solution to a Placebo Solution for Relief of Pain in Acute Otitis Media Subjects Aged 2 Months to 19 Years

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Children ages 2 months to less than 19 years old, who have been diagnosed with a middle ear infection may receive either medicated ear drops (AR01) or glycerin (placebo) ear drops. The patient or caregiver will measure the amount of ear pain before and after the ear drops to establish if the medicated ear drops decrease the amount of pain more than the placebo ear drops. The subject may leave the clinic 60 minutes after the first dose. The ear drops can be used up to 4 days, as needed for ear pain.

Study identification

NCT ID
NCT02074007
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Arbor Pharmaceuticals, Inc.
Industry
Enrollment
178 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
2 Months to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2013 (Type not available)
Primary completion
Jun 2014 (Actual)
Completion
Jun 2014 (Actual)
Last update posted
Jan 24, 2017

2013 – 2014

United States locations

U.S. sites
21
U.S. states
12
U.S. cities
19
Facility City State ZIP Site status
Clinical Research Consortium Arizona Phoenix Arizona 85004 —
Kern Allergy and Medical Research, Inc Bakersfield California 93301 —
Central California Research Fresno California 93720 —
Pharma Research International, Inc Naples Florida 34102 —
SCORE Physician Alliance, LLC St. Petersburg Florida 33710 —
Kentucky Pediatric / Adult Research Bardstown Kentucky 40004 —
Pioneer Clinical Research, LLC Bellevue Nebraska 68005 —
Omaha ENT Clinic Omaha Nebraska 68130 —
Children's Health Center / St. Elizabeth Medical Center Utica New York 13502 —
Valley Stream Pediatrics Valley Stream New York 11580 —
Haywood pediatric and Adolescent Medicine Group, PA Clyde North Carolina 39721 —
Sterling Research Group, LTD Cinncinati Ohio 45246 —
Central Ohio Clinical Research Columbus Ohio 43207 —
Urgent Care Specialists Hometown Urgent Care Columbus Ohio 43214 —
Carolina Ear, Nose & Throat Clinic Orangeburg South Carolina 29118 —
PMG Research of Bristol Bristol Tennessee 37620 —
Holston Medical Group Kingsport Tennessee 37660 —
Tanner Clinic Layton Utah 84041 —
Foothill Family Clinic South Salt Lake City Utah 84121 —
Heartland Research Associates LLC - Augusta Salt Lake City Utah 84121 —
Van Dorn Pediatrics Alexandria Virginia 22302 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02074007, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 24, 2017 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02074007 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →